Evidence map›Paper›PMID 39942571›Full record

ArticleMolecules (Basel, Switzerland)2025

Antioxidant and Anti-Inflammatory Effects of Vanillic Acid in Human Plasma, Human Neutrophils, and Non-Cellular Models In Vitro.

Anna Magiera, Joanna Kołodziejczyk-Czepas, Monika Anna Olszewska

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Nutrients · 2026
    Article
  3. Article
  4. Review
  5. Box-Behnken Design Optimization of High-Pressure Processed Bitter Melon (International journal of molecular sciences · 2026
    Article
  6. Effects of anVeterinary sciences · 2026
    Article
  7. Bypass Treatments for Primary Coenzyme Q10 Deficiency: An Update.International journal of molecular sciences · 2026
    Review
  8. Review
  9. Article
  10. Investigating a newBiotechnology reports (Amsterdam, Netherlands) · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna MagieraDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, 1 Muszynskiego St., 90-151 Lodz, Poland.ORCID 0000-0003-2437-3242
Joanna Kołodziejczyk-CzepasDepartment of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska, 90-236 Lodz, Poland.ORCID 0000-0001-8849-1067
Monika Anna OlszewskaDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, 1 Muszynskiego St., 90-151 Lodz, Poland.ORCID 0000-0001-8468-1365

Funding

Medical University of Lodz 503/3-022-01/503-31-001
6 · The paper itself

Abstract

Vanillic acid (VA) is a dietary benzoic acid derivative, flavoring agent, and food stabilizer. In this study, the antioxidant and anti-inflammatory potential of VA was explored in vitro and ex vivo in human immune cells and non-cellular models. In neutrophils, VA significantly downregulated the

Indexed as

Anti-Inflammatory AgentsAntioxidantsNeutrophilsVanillic AcidCytokinesHumansLeukocytes, MononuclearLipid PeroxidationOxidative StressReactive Oxygen SpeciesAnti-Inflammatory AgentsAntioxidantsCytokinesReactive Oxygen SpeciesVanillic Acid4-hydroxy-3-methoxy benzoic acidneutrophilsPBMCsplasma protectionprotein glycation

Identifiers

PMID39942571
PMCPMC11820348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.